BREAKING: German regulators have green-lit the EU's first psilocybin compassionate access program.
Unlike other countries’ pre-approval pathways, Germany’s does not require case-by-case regulatory approval and may see insurers cover costs.
Details: psychedelicalpha.com/news/germany...
Germany has become the first EU country to allow legal access to psilocybin under a compassionate use program for treatment-resistant depression. Unlike other countries’ pre-approval pathways, Germany...
